2014 Speakers

BioOhio is proud to present an amazing line up of speakers, moderators and panelists for the 2014 BioOhio Annual Conference Road Show. Please refer to the agendas for each venue for the schedule and topics.


William S. Ball, M.D., Vice President for Research, Professor Radiology, Biomedical Engineering and Pediatrics, University of Cincinnati

Speaking at the Northern & Central Annual Conferences

Dr. Ball received his degree in biochemistry from Louisiana State University, is a graduate of Tulane Medical School, and is board certified in both pediatrics and radiology with certification in Neuroradiology. In 1991, Dr. Ball developed and created the Imaging Research Center at Cincinnati Children’s. Dr. Ball has written over 123 scientific contributions and 11 book chapters. He became chair of the Department of Biomedical Engineering at UC in 2001. Dr. Ball later returned to Cincinnati Children’s Hospital as full-time attending staff neuroradiologist where he continued his research in pediatric cerebrovascular occlusive disease with a focus on Sickle Cell Disease. He returned to the university in 2011 and would become permanent vice-president for research in 2012.


Jason E. Barkeloo, Founder & CEO, Bacterial Robotics

Speaking at the Southern Annual Conference

Jason has over twenty years of experience as a technology entrepreneur, researcher, investor, and educator. His undergraduate degree in Anthropology is from The Ohio State University. His Master’s degree in Education has certifications in biological sciences and social studies from Antioch University. After a US Army career, Jason taught sciences through the Department of Defense Troops to Teachers program. He completed the pre-Physician Assistant (PA) program at the Kettering College of Medical Arts. Instead, of accepting admission to the PA program, Jason became an entrepreneur. Bacterial Robotics is his fifth startup.


Mike Carrel, President & CEO, AtriCure, Inc.

Speaking at the Southern Annual Conference

Under his leadership, AtriCure is executing on the company’s promise to decrease the global atrial fibrillation (Afib) epidemic by investing significantly in education, clinical science and product innovation. Prior to joining AtriCure in 2012, Mr. Carrel served as the President & CEO of Vital Images, a medical imaging software company, where he grew revenue and profitability, expanded its presence to over 90 countries, and raised $100M dollars in equity financing. Mr. Carrel is on the American Heart Association Board of Directors for the Cincinnati and Minneapolis Chapters. He holds a BS in Accounting from Pennsylvania State University and an MBA from the Wharton School at the University of Pennsylvania.


Andrew Cothrel, CEO, NovoSource

Speaking at the Southern & Central Annual Conferences

Andrew Cothrel is CEO of NovoSource, an orthopedic implant company taking a novel approach to the reconstructive joint market. He has had a long career as a medtech/biotech executive, advisor, and consultant, covering diagnostics & patient monitoring, life science research tools, and medical devices including orthopedics, cardiovascular, and surgical tools. In recent years he founded Blue Marble Medical, offering consulting to early stage and Fortune 500 companies. Prior to that, he worked with Abbott, Boehringer Mannheim, and Roche. He currently resides in Oakwood, where he also serves on the faculty of the University of Dayton teaching entrepreneurial finance.


Frank L. Douglas, Ph.D., M.D., BioOhio Board Member, President & CEO, Austen BioInnovation Institute in Akron (ABIA)

Speaking at the Northern Annual Conference

An award-winning industry veteran with almost 30 years of experience as a leader in healthcare, pharmaceutical research and entrepreneurship, Douglas serves as day-to-day chief strategist for the Austen BioInnovation Institute in Akron (ABIA). Douglas has improved the health of millions of patients by leading the teams that were responsible for numerous drugs including Allegra, Lantus, Taxotere and Actonel. Douglas holds a Ph.D. in physical chemistry and a M.D. from Cornell University.


Gary M. Fingerhut, BioOhio Board Member, Executive Director, Information Technology Communication, Cleveland Clinic Innovations

Speaking at the Northern Annual Conference

Gary leads a talented team of professionals guided by some of the nation’s top venture capitalists. Gary has more than 30 years of technical and executive experience in the software industry, leading companies from start-up through acquisition. Prior to joining Cleveland Clinic in 2011, Gary held a number of senior level positions at Axentis, of which he is a co-founder. Axentis, a Wolters Kluwer business, is a software provider of on-demand solutions used by life science customers and other highly regulated industries to minimize their exposure to risk and optimize business performance. Gary serves on the board of directors of ImageIQ, Enforcer eCoaching, iVHR, Healthxl, BioEnterprise, Talis Clinical, i360 medical and iComet.


Joseph Gardner Ph.D., President & CEO, Aerpio Therapeutics

Speaking at the Southern & Central Annual Conferences

Joseph H. Gardner, Ph.D. founded Akebia in 2007 following twenty three years of pharmaceutical discovery and development work at P&G Pharmaceuticals.  As CEO of Akebia Joseph completed four rounds of private financing and moved the lead anemia drug, AKB-6548, successfully through Phase 2 studies in humans. Akebia’s 2014 IPO raised over $100M and is now a publically traded company on NASDAQ. In 2011 Joseph spun out the Tie2 and HIF1 activator projects, into Aerpio Therapeutics. As CEO of Aerpio, Dr. Gardner successfully closed two series A financings which will fund research through human proof of concept studies in patients with diabetic macular edema. Dr. Gardner received his BS with honors in Biological Chemistry from Tulane University, earned his MS in Biochemistry from Utah State University and Ph.D in Medicinal Chemistry from University of Wisconsin.


Roger A. Gilcrest, Partner, Ice Miller LLP

Speaking at the Central Annual Conference

Roger Gilcrest enjoys working with inventive and creative companies to recognize, protect and profit from their inventions and creative work product. Roger focuses his practice on intellectual property, patent, trademark, copyright, trade secret, unfair competition and computer law practice. Roger has extensive experience in the preparation and prosecution of domestic and foreign patent applications. These applications involve inventions in the chemical, biochemical/biotechnological and mechanical arts. He also has experience in litigation of patent infringement claims in the federal Courts and in the appeal of issues of patentability before the Patent Office Board of Appeals.


Al Hawkins, Vice President, Business Development, BioMotiv

Speaking at the Northern Annual Conference

Al Hawkins has broad expertise in developing new biomedical companies based on technologies licensed and identified from universities, hospitals and federal labs. He has spent his career at the intersection of academic institutions and start-up companies in the life sciences as an entrepreneur, fund manager, and university tech transfer officer. Mr. Hawkins was most recently CEO-in-Residence at BioEnterprise, where he launched and helped secure funding for two spin-out companies from academic institutions. Prior to BioEnterprise, Mr. Hawkins was the Director of New Ventures at Boston University, where he managed spin-out companies from the institution’s $400 million annual research budget. He serves as a frequent SBIR grant reviewer for NIH and in 2012, was awarded the Young Entrepreneur Initiative Fellowship from the French government.


Jeff Held, Rapid Prototype Lead, Human Centric Design, Battelle Medical Device Solutions

Speaking at the Central Annual Conference

Mr. Held has over twenty years of experience in the Rapid Prototyping industry and has a degree in Design Technology from The Art Institute of Pittsburgh. He has been a key part of the rapid prototyping capability at Battelle for over sixteen years, working on medical devices, consumer products, bio-tech markets and U.S. Military projects. When additive manufacturing isn’t the right tool for the job, Mr. Held utilizes a full suite of fabrication equipment to produce prototypes that require properties such as hand fabrication or high tolerance parts. In 2002, Mr. Held was part of the design team that developed future-looking medical device concepts that were awarded two IDEA awards in the Design Explorations category.


Kathleen Hilliard, BA, CCRC, Manager, Clinical Trials Operations, Ohio Clinical Trials Collaborative (OCTC)

Speaking at the Southern & Northern Annual Conferences

Kate Hilliard’s career began in industry as a preclinical toxicologist, in the Pharmacology and Drug Development Section at the Battelle Memorial Institute. Over the past 20 years, she has developed expertise in cystic fibrosis through the coordination of clinical studies and management of regulatory affairs and operations. She has served on several national committees for the CF Therapeutics Development Network and has developed a national research coordinator mentoring program. Hilliard is currently Director of Clinical Research Operations for the Department of Pediatrics’ Division of Pediatric Pulmonology and Allergy/Immunology at the University Hospitals Rainbow Babies and Children’s Clinical Research Center.


James Huttner, MD, Ph.D., Medical Director, Vice President Product Development, Bionix Development Corporation

Speaking at the Northern Annual Conference

James Huttner received his medical degree from the Medical College of Ohio and Ph.D. from The Ohio State University, with residency at UTMC, followed by 25 years of general practice in pediatrics in Maumee, Ohio. James’ idea for a plastic ear curette came during his residency in 1982, and in 1984 he co-founded Bionix to manufacture and sell ear curettes and other medical devices. Since then, Bionix has added or acquired over 200 products, and has grown staff and facilities. Now with over 70 Toledo area employees and a Philadelphia office, Bionix sells products throughout the U.S. and to more than 52 countries. Recently, James started JAZ Innovations to focus on non-medical products. He continues to stay active in medicine, serving as Director for Pediatric Medical Education for Toledo Children’s Hospital, and has joined the Ohio-1 DMAT team.


Luke Kellett, Director of Business Development, Heath-Newark-Licking County Port Authority

Speaking at the Central Annual Conference

Luke Kellett is the Director of Business Development for the Heath-Newark-Licking County Port Authority. Luke is a DeVry graduate and specializes in marketing and finance, with over 11 years of experience. Luke is the lead for Potentia Finance, Economic Gardening, and Marketing for the Port Authority. The Heath-Newark-Licking County Port Authority was created in 1995 to take over ownership of the Newark AFB upon closing. Today, it has a three-fold mission of management, development, and leadership for county-wide economic development efforts.


Jack Kraeutler, CEO, Meridian Bioscience

Speaking at the Southern Annual Conference

John A. Kraeutler has over 43 years of experience in the biomedical industry and was appointed CEO of Meridian Bioscience in 2008 after holding the position of President & COO of since 1992. Before joining Meridian, Mr. Kraeutler served as Vice President, General Manager for a division of Carter-Wallace, Inc. He has a BS in Biology from Fairleigh Dickinson University, an MS in Biology and an MBA in Marketing from Seton Hall University. Mr. Kraeutler serves on the Board of Directors of Assurex, the Cincinnati USA Regional Chamber, and is a former member of the Ohio Third Frontier Commission and a former Vice Chairman of BIOSTART.


Neill Lane, President & CEO, Stirling Ultracold/Global Cooling

Speaking at the Central Annual Conference

Neill Lane is President & CEO of Global Cooling, makers of the Stirling Ultracold line of ultra-low freezers. Previously, he was a Co-Founder & President of Blight to Bright, an Ohio developer of large-scale solar installations. He served as Executive-in-Residence with TechGROWTH Ohio, a pre-seed fund providing for early stage technology companies, and for 10 years as President and CEO of Sunpower. Mr. Lane was born and grew up in Zimbabwe, graduating with a degree in mechanical engineering from the University of the Witwatersrand, South Africa. He started his career as a lecturer in thermodynamics and has worked in clean energy his entire career, from developing biofuels as a graduate student to leading the development of world’s first solar thermal free-piston Stirling engine.


T. Earl LeVere, Partner, Ice Miller LLP

Speaking at the Northern Annual Conference

T. Earl LeVere focuses his practice on intellectual property and information technology issues related to patent, copyright, trademark, life sciences, computer law, internet, e-commerce disputes and entertainment law. Earl has represented clients in intellectual property litigation matters throughout the country; helped clients establish internal procedures to protect proprietary information; drafted IP license and assignment agreements and agreements for the joint development and use of intellectual property. Earl received his Bachelor of Arts from Capital University, summa cum laude, in 1990 and his juris doctorate, with honors, from The Ohio State University College of Law in 1994.

Lewis 240 248

John F. Lewis, Jr., BioOhio President & CEO

Speaking at the Southern, Northern & Central Annual Conferences

John F. Lewis, Jr., a 4th generation Ohioan, is the President & CEO of BioOhio, Ohio’s bioscience membership organization. He is a licensed attorney with experience in international business, venture capital investments and economic development. He was a founding partner of the First Fifty Fund and Ohio TechAngel Fund. John has more than 18 years international experience, lived in Jamaica, Korea and China, the latter two with Perkin Elmer, while traveling to more than 42 others. A graduate of Miami University (Ohio) and Capital University Law School, John is married to Judy Huang and has one daughter.


John W. Manzetti, President and CEO, Pittsburgh Life Sciences Greenhouse | Founder and Managing Director, PLSG Accelerator Fund

Speaking at the Northern Annual Conference

John Manzetti and his team at PLSG have worked with more than 400 companies, invested directly in 75 for over $20 million, which has created over $1.8 billion in conservative market valuation. John is also the Founder and Managing Director of the PLSG Accelerator Fund, an early-stage venture fund focused on high-impact investments in the life sciences and Healthcare sectors. John is a visionary financial and corporate leader, technology entrepreneur, investor, start-up advisor and expert on the topics of venture capital formation, economic development and the commercialization of innovation. He is globally recognized for his prowess in taking innovation from “Concept to Commercialization” and market entry.


Katherine K.C. McAllister, EVP, Business Operations, Taylor Strategy Partners

Speaking at the Southern Annual Conference

Upon graduation from the University of Notre Dame, K.C. joined Taylor Strategy Partners and rose quickly through the ranks to her current position as Executive Vice President of Business Operations. She has delivered on senior level searches and strategic talent acquisition programs with the firm’s key clients while managing TSP operations to ensure support for all services. K.C. is an active member in many industry associations including the Healthcare Businesswoman’s Association (which named her a 2014 HBA Luminary) and Society for Human Resource Management.


Stephen McHale, Co-Founder & CEO, Explorys

Speaking at the Northern Annual Conference

Stephen McHale has had a 25-year career in founding, investing in and building technology companies. He is recognized for his focus in data mining and business intelligence related ventures. In 1985, Stephen founded McHale and Associates, and most recently served as the Chairman & CEO of Everstream, the largest census level media measurement, data warehousing, and analytics platform in the world. Stephen serves on the board of directors for the Center for Families and Children; a non-profit organization that makes success possible for people in Northeast Ohio’s most challenged communities. He is also an active member of the Entrepreneurs Organization and Kent State University’s Health Informatics Advisory Council.


Daniel M. Miller, MD, PhD, Medical Director, Cincinnati Eye Institute

Speaking at the Southern Annual Conference

Born in Youngstown, Ohio, Dr. Miller received a Bachelor of Science in Biology from the University of Michigan, completed a combined MD/PhD curriculum at the Ohio State University College of Medicine where he combined doctoral research with his medical education. He has an extensive background in basic and clinical research, including macular degeneration, diabetes, and vitreoretinal surgery and has presented this work in international clinical and scientific meetings. Dr. Miller specializes in all medical and surgical retinal diseases and sees patients in Middletown and Blue Ash.


Richard C. McQuown, Partner, Porter Wright

Speaking at the Central Annual Conference

Rick has a diverse practice that includes counseling emerging businesses and seasoned private companies in general business matters, choice of entity, corporate governance federal and state securities law compliance, strategic partnerships, and mergers and acquisitions. Rick also represents lenders and borrowers in asset-based lending transactions and acquisition financing. In the health care industry, Rick has counseled physician groups and health care entities in all aspects of their businesses, including corporate governance, strategic relationships, affiliations and securities law compliance matters. Rick is the chair of Porter Wright’s Emerging Business Practice Group, Biotech Practice Group and Transportation and Logistics Practice Group.


Aram Nerpouni, President & CEO, BioEnterprise

Speaking at the Northern Annual Conference

Aram Nerpouni is President and CEO of BioEnterprise. In this position, he focuses on strategic initiatives as well as counseling clients on business and financial matters. Nerpouni rejoined BioEnterprise in 2011 as Vice President of Strategic Initiatives after serving as the Chief Administrative Officer and a Founder of the Austen BioInnovation Institute in Akron. He was previously a Vice President of Business Development at BioEnterprise and has also worked as Director of International Markets and Director of Marketing at The Bonne Bell Company. Nerpouni serves on the Board of Child Guidance and Family Solutions in Akron and the Knight Foundation Community Advisory Committee. He received an MBA from Case Western Reserve University and a BS in Biology from Stanford University.


Jim Ohneck, Global Senior Vice President/Principal Client Advisor, Valtronic

Speaking at the Northern Annual Conference

Mr. Ohneck has worked on the development of many high tech devices relating to biochemistry analyzers, ophthalmic surgical systems, operating microscopes, lasers, micro endoscopes, neuro-stimulators and biosensors. He has a patent pending on a therapeutic laser system used to treat chronic pain. His technical and business expertise gives him unique insight into reviewing, developing and commercializing products for the medical industry. He received a B.S.B.A. from the University of Phoenix and an AAS in Electronic Engineering Technology from the University of Hartford. Mr. Ohneck has over thirty years’ experience in the medical device industry, including product management, international sales and executive marketing management. He has been involved in senior management positions of start-up, high tech medical companies since 1992.


John Paganini, MBA, CPHIMS, CIIP, Sr. Manager, Interoperability Initiatives, HIMSS (Healthcare Information and Management Systems Society)

Speaking at the Northern Annual Conference

Paganini joined HIMSS in 2013 as on-site senior manager for the HIMSS Innovation Center. He manages interoperability/technology initiatives, operations, and logistics. These responsibilities include the design and execution of programs for marketing, technical design and implementation, education, scheduling and relationship management. With over 35 years of IT and healthcare information systems experience, Paganini’s expertise focuses on systems integration, pathology, electronic medical records, RIS/PACS/CAD workflow solutions, HIPAA and meaningful use compliance. Previously, he was the Owner/President of Paguar Informatics, a health IT consulting firm, and was co-founder of RIS Logic, now a division of Merge Healthcare.


Dan Paoletti, CEO, The Ohio Health Information Partnership

Speaking at the Central Annual Conference

Dan Paoletti has been at the helm of the Ohio Health Information Partnership as CEO since 2011. Because of his former position as Vice President of the Ohio Hospital Association (OHA) and COO of OHA Solutions, he brings tremendous knowledge of hospital and health systems to the Ohio Health Information Partnership. Dan’s collaborative spirit brings sometimes diverse and competitive entities together to work on what is best for our healthcare system and the citizens of Ohio. As one of the founding board members of The Partnership, Dan has helped shape the vision, mission and policies since its inception in 2009. With more than 20 years of experience in the healthcare industry, his sales, management and health information technology expertise have influenced the start-up and success of the nonprofit.


Jay Perkins, Vice President and Engineer, Design Central

Speaking at the Central Annual Conference

Jay Perkins is Vice President of Design Central, an innovation consultancy located in Columbus, Ohio. Jay is a mechanical engineer with a varied professional background including experience in robotics, software, defense, sporting goods, medical, consumer and commercial products. As his passions lie in both technical and artistic aspects of his work, Jay is a highly creative problem solver. During his tenure as the engineering lead at Design Central, Jay has successfully guided his clients through the product development process on over 300 projects, resulting in his inclusion in over 50 design and utility patents. Jay has degrees in engineering from the University of Kentucky and Purdue University.


Joseph Peter, BSBA, MA, MBA, PMP, Manager, Network Operations, Ohio Clinical Trials Collaborative (OCTC)

Speaking at the Central Annual Conference

Joseph Peter began his career in engineering and manufacturing software. He held positions of increasing authority to include Information Technology operations for a two billion dollar manufacturing company which later transitioned into leading large scale complex software development projects in the financial industry. Recently he successfully led and completed the CWRU Regional Extension Center/HiTech Grant, resulting in a high adoption of electronic health records and achievement of meaningful use in Cleveland as well as in several nearby counties.


Ken Phelps, Owner, Camargo Pharmaceutical Services

Speaking at the Northern Annual Conference

Ken Phelps employed more than three decades of experience in the health science and services industry to found Camargo in 2003. As an expert in drug development, specifically the 505(b)(2) pathway, he has aided in FDA approval of numerous compounds. Prior to Camargo, he held executive positions in quality control, project management and regulatory, clinical and medical affairs at Duramed Pharmaceuticals. Before Duramed, Mr. Phelps had global responsibility with Merrell-National Labs for QA/QC and processing technology, and later directed IT for multinational manufacturing. He began his career synthesizing, characterizing and performing drug metabolism studies of potential carcinogens with the Eppley Center for Research in Cancer.


Aaron Pitts, Managing Director, BioHealth & Agribusiness / Food Processing, JobsOhio

Speaking at the Southern, Northern & Central Annual Conferences

As managing director, Aaron Pitts has responsibility for defining and executing growth strategies for Ohio’s BioHealth and Agribusiness & Food Processing industries. Aaron joined JobsOhio in 2013 after spending the past 12 years at Cardinal Health where he focused on strategy, business development, and general management roles for the $100b global healthcare services company. Previously, Aaron held management consulting positions with Ernst & Young and PricewaterhouseCoopers where he executed operations strategy initiatives across consumer packaged goods, food processing, healthcare, and financial services sectors. Education: University of Minnesota, MBA; The Ohio State University, BSBA.


Sam Privitera, Vice President of R&D, Bard Medical, a division of C.R. Bard

Speaking at the Central Annual Conference

Sam Privitera has 26 years of product development experience addressing new clinical opportunities that span a breadth of users and disease states. At Bard Medical, Sam is currently responsible for the NPD portfolio management, product development, intellectual property, and sustaining engineering. Product-lines include Interventional Urology, Urologic Drainage, Therapeutic Hypothermia, Brachytherapy, and Home Health Care. Prior to joining Bard, Sam was VP of R&D at AtriCure, Group Director of New Product Development at Johnson & Johnson’s Ethicon Endo-Surgery, and began his career at Fisher-Price, developing juvenile products and supporting processes. He has a BS in Mechanical Engineering, an MBA and a JD. Sam recently received his 31st patent with over 40 applications still in prosecution.


Stephen Rapundalo, Ph.D., President & CEO, MichBio

Speaking at the Southern Annual Conference

Dr. Rapundalo, has broad experience in the life sciences, with an extensive background in pharmaceutical R&D. Prior to joining MichBio in 2006, he spent almost 20 years as a senior research scientist, project manager, and group leader with Parke-Davis Pharmaceutical Research and Pfizer, primarily in the area of cardiovascular drug discovery as well as developing a change management program to improve Pfizer’s worldwide R&D business processes. He has a strong background in innovation and is an expert in technology areas including high-throughput screening and proteomics. Dr. Rapundalo has over 50 publications, book chapters, and monographs, and has served as a peer-reviewer for prominent scientific journals and national funding agencies.


Jan Rosenbaum, Ph.D., Chief Scientific Officer, Airway Therapeutics

Speaking at the Southern Annual Conference

Dr. Rosenbaum has over 22 years of drug development experience, including technical management positions in big pharma, leading development of small molecule, peptide, and protein therapeutics. She retired from P&G in 2009 and joined CincyTech as Director of Life Sciences with responsibility for creating life science startups in Southwest Ohio. She has been involved with Airway since 2011, becoming CSO in 2013. With over 50 publications and expertise in Molecular Pharmacology and Developmental Biology, she holds a Visiting Scholar position at the University of Cincinnati, where she co-created a graduate level Drug Discovery course. She holds an Adjunct Professor position at The Ohio State University where she lectures in Pharmacogenomics.


Thomas J. Rosol, DVM, Ph.D., Diplomate ACVP; Professor, Veterinary Biosciences & The James Comprehensive Cancer Center; Senior Advisor, Life Sciences, University Office of Technology Commercialization, The Ohio State University

Speaking at the Central Annual Conference

Thomas Rosol, DVM, PhD has served as Dean of the College of Veterinary Medicine and Vice President for research at OSU, and on advisory boards to the National Institutes of Health, United States Department of Agriculture, American Veterinary Medical Association, and Morris Animal Foundation. Rosol serves as a consultant for industry in preclinical safety in the areas of endocrine, bone, and reproductive pathology and animal models of cancer. Recent work focuses on prostate, breast, and head and neck cancer. He has served as a mentor for over 40 PhD graduate students and postdoctoral trainees. Rosol is a fellow of the American Association for the Advancement of Science and was recognized by OSU as a Distinguished Scholar, one of the universities’ highest honors.


Frank Samuel, President, VentureOhio

Speaking at the Southern Annual Conference

Frank Samuel is President of VentureOhio, founded in 2013 to advance entrepreneurial growth in Ohio. Previously, he was founding President of the Geauga Growth Partnership, a business-led economic development organization in Geauga County, Ohio. He was Science and Technology Advisor to the Governor of Ohio from 2000 – 2007, when he was a principal architect of Ohio’s Third Frontier program. Samuel currently serves on the Board of Directors of the Global Cardiology Innovation Center of the Cleveland Clinic. A graduate of Hiram College and Harvard Law School, his paper recommending a venture capital strategy for the Great Lakes region was published in 2010 by The Brookings Institution.


David Scholl, Ph.D., BioOhio Board Member, Partner, Athenian Ventures

Speaking at the Southern Annual Conference

Dr. David Scholl was President/CEO of Diagnostic Hybrids, Inc. (DHI) in Athens, Ohio from 1995 to 2010. Founded in 1983, DHI grew to be a world leader in cell- and MAb-based clinical virology diagnostics. In 2010 the company was acquired by Quidel Corporation and Dave served on the Quidel senior executive team through October 2011. He is currently a healthcare partner with the venture capital firm Athenian Venture Partners. Dave serves on numerous boards including BioOhio, the Ohio Third Frontier Commission, and is a trustee of Ohio University and the Ohio University Foundation.


Mike Sieron, BioOhio Board Chair and President & CEO, DG Medical

Speaking at the Central Annual Conference

Mr. Sieron is the President, CEO of DG Medical, and has worked for a number of both publicly traded and private companies in his career including AcuTemp, Thermo Electron, and the Swedish company Sunds Defibrator. Mr. Sieron professional accomplishments include sitting on various Boards of Directors in fiduciary and advisory capacities, successfully executing several acquisitions, setting up various global sales networks and being awarded numerous patents. Mr. Sieron holds a Bachelor of Science degree in Mechanical Engineering and a minor in Business from the University of Cincinnati. He has continued his education with executive education courses in finance, management, and other disciplines from The Kellogg School of Management at Northwestern University and Xavier University.


Adam Singer, Director, BioHealth Cluster, REDI Cincinnati

Speaking at the Southern Annual Conference

Adam is the Director of the BioHealth Cluster for the Cincinnati USA Partnership. Mr. Singer works to increase the economic impact of the BioHealth cluster by developing and implementing plans to accelerate growth of existing companies as well as to attract new businesses to the region. Before working for the Partnership, Adam spent the last 10 years in the medical device sector, holding several key positions with the most recent being Director of Sales for a medical device distribution company. Mr. Singer holds a BS degree from Miami University in Oxford, OH and a MBA with a specialization in Entrepreneurship from Northeastern University in Boston, MA.


Tony Siracusa P.E., Vice President & General Manager, US Endoscopy (STERIS)

Speaking at the Northern Annual Conference

Tony Siracusa joined US Endoscopy in 2005 as Vice President of Manufacturing Operations, promoted to COO in 2009, and named Vice President & General Manager in 2013. Tony is responsible for P&L, managing daily operations to help the company successfully execute on its one and five-year business plans, and for providing leadership and direction to the organization to ensure that the company’s mission and objectives are achieved. He is experienced in the manufacture of Medical Devices for the Endoscopic and Diagnostic Imaging Medical Industries, accustomed to operating facilities under FDA regulatory compliance along with meeting subsequent international standards, and effectively manages in a fast-paced, dynamic environment increasing production, improving quality and growing revenues/profits.


Jon J. Snyder, BioOhio Board Member, President & CEO, Neuros Medical

Speaking at the Northern Annual Conference

Jon J. Snyder is the Founding President and CEO of Neuros Medical, Inc., a Cleveland, Ohio based neuromodulation company focused on developing proprietary therapies for unmet needs to patients worldwide. He holds over 20 years of global management experience in biomedical and healthcare sales, marketing, and operations with significant experience in bringing new products into the marketplace. His background covers business development, product development, market management, sales management, venture capital investment, and fundraising at start-up and Fortune 500 (Top 20) companies including Cyberonics, Cardinal Health, Imalux, and STERIS. Snyder has a B.S. from Ohio University.


Sunnie Southern, MS, RD, LD, Founder & CEO, Viable Synergy, LLC | Creator, Innov8 for Health

Speaking at the Southern & Central Annual Conferences

Sunnie Southern is the Founder & CEO of Viable Synergy, a health technology and innovation firm, and the creator of the Community Innovation Program, Innov8 for Health. Sunnie is passionate about connecting innovative solutions with people who need them most. Her career includes launching over 30 products in a wide variety of health conditions, industries, and health care environments. This work has afforded her the opportunity to help 100s of health innovators around the world bring their ideas to life to support health care providers and help patients achieve their health goals.


James J. Stoodt, Senior Vice President, Market Development and Member Services, The Healthcare Colloquium (a Battelle Company)

Speaking at the Central Annual Conference

James Stoodt is a Health IT veteran with more than 28 years of experience with EHRs, interoperability, mobility, and advanced analytics. He has led business development and delivery initiatives for large health systems/IDNs, software companies and entrepreneurial ventures. The Healthcare Colloquium transforms healthcare organizations by improving patient outcomes through a collaborative approach to heart failure accreditation, data-driven quality improvement methodologies, and patient-level predictive analytics.


Antonie J. (Ton) van den Bogert, Ph.D., Parker-Hannifin Endowed Chair in Human Motion and Control in the Department of Mechanical Engineering, Cleveland State University

Speaking at the Northern Annual Conference

For most of his career, Ton has worked on computational modeling of human movement and computer-aided movement analysis, with applications in rehabilitation, sports, and animation. Antonie has previously been on the faculty at the University of Calgary and the Cleveland Clinic. His academic degrees are from the University of Utrecht (Netherlands). He has published over 130 journal articles and book chapters, and sits on the editorial boards of three scientific journals. Current research interests are control of powered prosthetic and orthotic devices, and predicting the effect of sports equipment and rehabilitative devices on human movement and performance.


Sandra L. Vance, MHA, Senior Director, Interoperability Initiatives, HIMSS (Healthcare Information and Management Systems Society)

Speaking at the Central Annual Conference

Sandra Vance is Senior Director, Interoperability Initiatives at HIMSS. Prior to joining HIMSS, Vance worked as an IT Manager for a large health system in Columbus where she developed new processes and provided oversight for technology transitions as physician practices were acquired by the health system. Her experience at OhioHealth includes work on all phases of clinical system implementation in both ambulatory and inpatient settings. As Senior Analyst, Vance led technical integration of clinical information systems for the opening of one of America’s first paper lite hospitals. She holds her Bachelor of Business Administration (cum laude) from Mount Vernon Nazarene University, a Master of Health Administration from The Ohio State University, and Information Technology Infrastructure Library certification.


Don Wetherhold, President & CEO, Aprecia Pharmaceuticals

Speaking at the Southern Annual Conference

Don Wetherhold is the CEO of Aprecia Pharmaceuticals Company, a unique specialty pharmaceutical company built upon an innovative and proprietary three dimensional printing (3DP) technology platform originally developed at MIT for use in pharmaceutical applications. Aprecia’s 3DP platform can give rise to multiple product enhancing dosage forms. The company expects that its initial products will be based on its proprietary, orally-dispersing ZipDose® technology. Wetherhold has 27 years of experience in the healthcare industry, including key management positions and leadership roles at Omnicare, Cardinal Health, Snyder Healthcare Sales, and Solvay Pharmaceuticals.


Mark Woodka, CEO, OnShift, Inc.

Speaking at the Northern Annual Conference

Mark joined OnShift in July, 2008 as CEO. Mark brings over 25 years of experience in enterprise software sales and marketing with startup organizations and Fortune 500 companies. Prior to OnShift, Mark was Vice President of sales for Flashline, acquired by BEA in 2006. Mark successfully developed and implemented Flashline’s global sales and channel strategy and later BEA’s aqualogic sales team. Mark’s track record creating and running successful business strategies includes work with TMW Systems, where he built the sales team from the ground up leading to over 1500% increase in revenue, and PSI, a regional hardware and software VAR. Mark leverages his extensive background in technology-enabled process improvements speaking at industry conferences as well as authoring articles on long-term care trends and issues.


Elisabeth H. Young, M.D., FACP, Vice Dean, College of Medicine, Professor of Internal Medicine, Northeast Ohio Medical University (NEOMED)

Speaking at the Northern Annual Conference

Dr. Young has more than 20 years’ experience in a variety of health care settings across Northeast Ohio. She currently serves as Associate Medical Director at Humility of Mary Health Partners, Hospice of the Valley, where she practices hospice and palliative care. A graduate of NEOMED herself, Dr. Young educates and trains up-and-coming physicians, holding key roles in the College of Medicine. As Vice Dean, she is responsible for strategic planning, academic affairs, and interprofessional education and outreach. Previously, Dr. Young was in private rheumatology practice for 13 years and served as Director of Graduate Medical Education at St. Elizabeth Medical Center in Youngstown.